COMPANY NEWS

22-Oct-2007
NPRI Appoints Stauber as Distributor of Specialty O2PTM Powders

Will Also Collaborate in Developing Unique Health-Specific Formulations Using the Patented O2P Oil-to-Powder Process to Select Nutraceutical Product Marketing Companies


Las Vegas, NV (October 22, 2007) - Nutri Pharmaceuticals Research, Inc. (NRPR.PK), a leading developer and marketer of powdered nutritional ingredients, announced that it has appointed Fullerton, California-based Stauber Performance Ingredients, Inc.., a leading provider of ingredients to nutraceutical, OTC, cosmetic and food manufacturers, as its distributor for NPRI's specialty O2TM Powders.

The agreement states that Stauber will serve as the lead distributor for specialty O2P powders and associated tolling services to nutraceutical and OTC marketers in the U.S. According to NPRI president, Godfrey Yew, "Stauber is one of the preeminent providers of specialty ingredients. With the addition of O2P Powders, they will now be able to offer their customers, and the end consumer, a range of bio-actives that were once only available in liquid or semi-solid form."

Commenting on the agreement, Stauber CEO, Mr. Dan Stauber, stated, "This is another strategic step in our efforts to offer our clients and the industry unique, value- building products. Having a unique family of bio-actives, powdered by the O2P technology, will enable us to offer nutraceutical and OTC manufacturers the ability to incorporate the DHA, GLA, ALA or EPA found in many fatty acids or the anti-oxidant properties found in nutritional oils. In this way, they will now be able to offer unique, efficacious and patentable products, whether as a functional beverage, supplement or specialty food product".

"Companies that were once limited to liquid softgels can eliminate concerns over BSE, stability or damage by migrating to a dry, two-piece hard capsule or tablet. Others can expand their product offerings with a parallel line of capsules, tablets or dry mix alternatives," he added.

About NPRI:
Nutri Pharmaceuticals Research Inc. (www.o2pus.com) provides a wide range of powdered oils for functional food, food supplement; pharmaceutical; cosmetic; pet food and animal feed applications.

The company is one of a select few to be awarded the prestigious Nutrition Business Journal "Product Merit Award" for its patent-pending O2TM Powderization process. The firm currently offers more than 50 shelf-stable powders, as well as contract tolling services.

Nutri Pharmaceuticals Research Inc. shares are currently traded in the United States on the "Pinksheets" under the symbol NRPR.PK.






COPYRIGHT ©2007-2008 Stauber Performance Ingredients, Inc. All rights reserved.